Retatrutide 30 mg

RT-2026-042Lot 2026-003Analyzed October 29, 2026

Timeline

Ordered

October 27, 2026

Received

October 28, 2026

Analyzed

October 29, 2026

Sample

Name

Retatrutide 30 mg

Expected

Retatrutide

Amount

1 vial, lyophilized powder

Testing

Client

JD Bioworks

Test type

Content & purity

Method

HPLC-UV

Content, how much is in it

33.41mg

Label claim: 30 mg

Purity, how clean it is

>99.9%

by HPLC-UV peak area

Chromatogram

HPLC-UV

17.96 min, Retatrutide, >99.9%

Analyst Comments

White lyophilized powder, lavender-cap vial, received sealed.

Analyst Signature

Max Barrett

Lab Director, PuriLab Analytical

Analysis date: October 29, 2026

Verification Code

RT-EXE5-F1KY

Verify at purilab.org/verify/RT-EXE5-F1KY

Scan to Verify

RT-EXE5-F1KY

Results apply solely to the sample as received and are not representative of any larger lot, batch, or production run. Findings are limited to the analytes stated above. PuriLab Analytical is an independent testing laboratory, is not CLIA certified or ISO 17025 accredited, does not sell or distribute any substance, and makes no representation as to the safety, legality, or fitness of any material for any use.

PuriLab Analytical|admin@purilab.org

Page 1 of 1